Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2023 | Improving the quality of life of patients treated with CAR-T therapy

Lorna Warwick • 24 Apr 2023
EBMT 2023
General CAR-T

Lorna Warwick, BA, Lymphoma Coalition, Toronto, Canada, emphasizes the importance of improving the quality of life (QoL) of patients treated with CAR-T therapy, highlighting some of the unmet needs in this space, including dealing with fatigue, improving communication with patients, providing more and better supportive care to patients dealing with anxiety and depression, and reducing barriers in access to care. This interview took place at the 49th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) held in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Lorna Warwick

Comparing the patient experience with CAR-T versus transplant in LBCL
1:15
Comparing the patient experience with CAR-T versus transplant in LBCL
Lorna Warwick • 24 Mar 2026
The value of integrating PROs into registry data
1:48
The value of integrating PROs into registry data
Lorna Warwick • 24 Mar 2026
Patient perspectives in the era of patient experience data: balancing clinician & patient priorities
2:42
Patient perspectives in the era of patient experience data: balancing clinician & patient priorities
Lorna Warwick • 24 Mar 2026
CAR T Vision: incorporating the patient perspective in the pursuit of improving access to CAR-T
3:06
CAR T Vision: incorporating the patient perspective in the pursuit of improving access to CAR-T
Lorna Warwick • 19 Jun 2025

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals